학술논문
FT538: Preclinical Development of an Off-the-Shelf Adoptive NK Cell Immunotherapy with Targeted Disruption of CD38 to Prevent Anti-CD38 Antibody-Mediated Fratricide and Enhance ADCC in Multiple Myeloma When Combined with Daratumumab
Document Type
ConferencePaper
Author
Source
BLOOD. 134
Subject
Language
English
English
English
ISSN
0006-4971